About
This application provides control for a specific medical simulation system on your iPad. It allows healthcare professionals to enhance procedural skills in endovascular therapies. The simulator covers various clinical areas like neurovascular and cardiovascular interventions.
What's New in VIST Remote
1.2
January 30, 2026
Updated with support for latest iOS 26 changes
Developer apps
FAQ
What is VIST Remote used for?
VIST Remote is an iPad application that adds controls for the Mentice VIST simulation system. It is designed to help healthcare professionals acquire and enhance their procedural skills in endovascular therapies.
Is VIST Remote free to download?
Yes, VIST Remote is available for free. The app has a 'Free' price listed and does not mention any in-app purchases or subscription requirements.
What devices does VIST Remote support?
VIST Remote is designed to work with iPads. The supported devices list explicitly mentions 'ipad'.
What age rating does VIST Remote have?
VIST Remote has an age rating of 17+. This indicates it is intended for mature users, likely due to the professional medical context of the simulation.
How often is VIST Remote updated?
The latest update for VIST Remote was on January 30, 2026, with version 1.2. This suggests a recent update, though the provided data indicates a future date for the last update.
Does VIST Remote have ads?
No, VIST Remote does not contain advertisements. The 'hasAds' flag is set to false, indicating an ad-free experience.
What clinical areas does the Mentice VIST simulator cover?
The Mentice VIST simulator, which VIST Remote controls, covers clinical areas such as neurovascular, cardiovascular, and peripheral interventions. This allows for training in a wide range of endovascular therapies.
Where can I find more information about the Mentice VIST simulator?
More information about the Mentice VIST simulator can be found on the Mentice website at https://www.mentice.com/vist-lab-with-vist-g5. The developer, Mentice Inc, is a leader in simulation solutions for endovascular therapies.
